Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04498481
What this trial is testing

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Who this might be right for
Breast Cancer
Pfizer 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT06239155
What this trial is testing

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Ascentawits Pharmaceuticals, Ltd 51
Not applicableStudy completedNCT06747026
What this trial is testing

Real-World Immuno-Radiotherapy for Advanced NSCLC

Who this might be right for
Lung Cancer Non-Small Cell Cancer (NSCLC)
Fengming Kong 338
Not applicableStudy completedNCT01631526
What this trial is testing

Vitamin D Loading Dose in Advanced Lung Cancer

Who this might be right for
Lung Cancer
Jewish General Hospital 80
Early research (Phase 1)Study completedNCT02897778
What this trial is testing

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Who this might be right for
NeoplasmsNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type+12 more
Syndax Pharmaceuticals 30
Early research (Phase 1)Ended earlyNCT01283178
What this trial is testing

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

Who this might be right for
Salivary Gland Squamous Cell CarcinomaStage II Salivary Gland CancerStage II Squamous Cell Carcinoma of the Hypopharynx+13 more
Virginia Commonwealth University 3
Testing effectiveness (Phase 2)Looking for participantsNCT07360743
What this trial is testing

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

Who this might be right for
Non Small Cell Lung Cancer (Squamous or Non Squamous)
UNICANCER 275
Large-scale testing (Phase 3)Ended earlyNCT00359476
What this trial is testing

Vinflunine in Patients With Gastric Cancer

Who this might be right for
Stomach Cancer
Bristol-Myers Squibb 55
Testing effectiveness (Phase 2)UnknownNCT04211168
What this trial is testing

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

Who this might be right for
Advanced Biliary Tract Cancer
Peking Union Medical College Hospital 44
Testing effectiveness (Phase 2)Study completedNCT00313248
What this trial is testing

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

Who this might be right for
Breast Neoplasm
Bayer 65
Very early researchNot Yet RecruitingNCT06825455
What this trial is testing

Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancersPeritoneal (metastatic) Cancer
Peking University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02983578
What this trial is testing

Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer

Who this might be right for
Advanced Colorectal CarcinomaAdvanced Lung Non-Small Cell CarcinomaLung Non-Small Cell Carcinoma+22 more
M.D. Anderson Cancer Center 39
Large-scale testing (Phase 3)Study completedNCT00152243
What this trial is testing

Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)

Who this might be right for
Gastric Cancer
Taiho Pharmaceutical Co., Ltd. 500
Testing effectiveness (Phase 2)UnknownNCT05880043
What this trial is testing

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Non-Hodgkin LymphomaRelapsed/Refractory Multiple Myeloma
GI Cell, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00479674
What this trial is testing

Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Duke University 41
Testing effectiveness (Phase 2)Study completedNCT05394285
What this trial is testing

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Henan Cancer Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00321685
What this trial is testing

Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer

Who this might be right for
Rectal AdenocarcinomaStage II Rectal Cancer AJCC v7Stage III Rectal Cancer AJCC v7
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT00030485
What this trial is testing

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07192185
What this trial is testing

Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received Atezolizumab & Bevacizumab

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 30
Early research (Phase 1)Study completedNCT03307785
What this trial is testing

Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

Who this might be right for
NeoplasmsMetastatic CancerAdvanced Cancer+4 more
Tesaro, Inc. 60
Next Page